{
  "company": {
    "name": "Bolt Biotherapeutics",
    "website": "https://boltbio.com/",
    "record": "https://startuphistory.org/c/boltbio.com"
  },
  "status": null,
  "history_since": "2018-08-05T19:30:13.000Z",
  "baseline": {
    "snapshot_id": "33d9445e91b2b240b2e19475539403124a01c93859bfc9a9e5443c82148e7861",
    "observed_at": "2018-08-05T19:30:13.000Z",
    "headline": "Bolt Biotherapeutics, Inc.",
    "description": null,
    "evidence": "https://web.archive.org/web/20180805193013/http://boltbio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T12:05:59.314Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2020-07-02T02:52:29.000Z",
      "variants": [
        {
          "headline": "Bolt Biotherapeutics, Inc.",
          "subhead": null,
          "observed_at": "2018-08-05T19:30:13.000Z",
          "evidence": "https://web.archive.org/web/20180805193013/http://boltbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bolt Biotherapeutics, Inc.",
          "subhead": "Bolt Biotherapeutics is developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).",
          "observed_at": "2019-07-22T16:25:05.000Z",
          "evidence": "https://web.archive.org/web/20190722162505/https://boltbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bolt Biotherapeutics, Inc.",
          "subhead": "Bolt Biotherapeutics is developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).",
          "observed_at": "2020-07-02T02:52:29.000Z",
          "evidence": "https://web.archive.org/web/20200702025229/https://boltbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Bolt Biotherapeutics, Inc.",
      "subhead": "Bolt Biotherapeutics is developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).",
      "from": "2018-08-05T19:30:13.000Z",
      "to": "2020-07-02T02:52:29.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20200702025229/https://boltbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-08-05T19:30:13.000Z",
          "to": "2020-07-02T02:52:29.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-09-08T12:59:36.000Z",
      "variants": [
        {
          "headline": "Finding better ways to treat cancer",
          "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
          "observed_at": "2024-07-15T03:18:11.000Z",
          "evidence": "https://web.archive.org/web/20240715031811/https://www.boltbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Finding better ways to treat cancer",
          "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
          "observed_at": "2026-01-22T17:44:32.000Z",
          "evidence": "https://web.archive.org/web/20260122174432/https://www.boltbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Finding better ways to treat cancer",
          "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
          "observed_at": "2026-09-08T12:59:36.000Z",
          "evidence": "https://web.archive.org/web/20260908125936/https://www.boltbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Finding better ways to treat cancer",
      "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
      "from": "2024-07-15T03:18:11.000Z",
      "to": "2026-09-08T12:59:36.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20260908125936/https://www.boltbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-07-15T03:18:11.000Z",
          "to": "2026-09-08T12:59:36.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T12:05:59.314Z",
      "variants": [
        {
          "headline": "Bolt Biotherapeutics has acquired Prana Therapies in conjunction with a $120 million private placement.",
          "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
          "observed_at": "2026-10-24T05:41:13.000Z",
          "evidence": "https://web.archive.org/web/20261024054113/https://www.boltbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bolt Biotherapeutics has acquired Prana Therapies in conjunction with a $120 million private placement.",
          "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
          "observed_at": "2026-11-05T12:05:59.314Z",
          "evidence": "https://www.boltbio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Bolt Biotherapeutics has acquired Prana Therapies in conjunction with a $120 million private placement.",
      "subhead": "Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.",
      "from": "2026-10-24T05:41:13.000Z",
      "to": "2026-11-05T12:05:59.314Z",
      "captures": 2,
      "evidence": "https://www.boltbio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-10-24T05:41:13.000Z",
          "to": "2026-11-05T12:05:59.314Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-89fd74ac91e6a430a878c594db776b9b1705fb8f128858ffe00942ee9321191e:4e7fdda8383e5e418582869431fcf033fde1b6f729bd37201a07b098721af3de:funding:efefba6f103681e4",
      "before_evidence": "https://web.archive.org/web/20190722162505/https://boltbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “He led Sunesis’ fundraising and partnering efforts, raising over $60 million in public funding and signing multiple deals with industry p…”.",
      "between": {
        "from": "2019-07-22T16:25:05.000Z",
        "to": "2020-07-02T02:52:29.000Z"
      },
      "evidence": "https://web.archive.org/web/20200702025229/https://boltbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-89fd74ac91e6a430a878c594db776b9b1705fb8f128858ffe00942ee9321191e:4e7fdda8383e5e418582869431fcf033fde1b6f729bd37201a07b098721af3de:compliance:784f18463d850bcc",
      "before_evidence": "https://web.archive.org/web/20190722162505/https://boltbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "compliance",
      "label": "Compliance",
      "summary": "Now states FDA-APPROVED compliance on its homepage.",
      "between": {
        "from": "2019-07-22T16:25:05.000Z",
        "to": "2020-07-02T02:52:29.000Z"
      },
      "evidence": "https://web.archive.org/web/20200702025229/https://boltbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-compliance"
    },
    {
      "n": 3,
      "id": "page-89fd74ac91e6a430a878c594db776b9b1705fb8f128858ffe00942ee9321191e:4e7fdda8383e5e418582869431fcf033fde1b6f729bd37201a07b098721af3de:investors:c7a1500ab2e6ca11",
      "before_evidence": "https://web.archive.org/web/20190722162505/https://boltbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: Novo Holdings, Vivo Capital, Piovtal bioVenture, Sofinnovo, NanFung Life Sciences, RACapital, Surveyor, RockSprings and 2 more.",
      "between": {
        "from": "2019-07-22T16:25:05.000Z",
        "to": "2020-07-02T02:52:29.000Z"
      },
      "evidence": "https://web.archive.org/web/20200702025229/https://boltbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    },
    {
      "n": 4,
      "id": "page-4e7fdda8383e5e418582869431fcf033fde1b6f729bd37201a07b098721af3de:48c6ffeda3a2a45b079de9812dbca3ee29c32dfd2105f18b8d2ffd1f1272b949:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20200702025229/https://boltbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2020-07-02T02:52:29.000Z",
        "to": "2021-07-08T07:48:11.000Z"
      },
      "evidence": "https://web.archive.org/web/20210708074811/https://www.boltbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 5,
      "id": "page-ae9f108897e4cd344d4b661192663dd4c39233945b063284cb33c732c4f4c592:e5126359d8ed73555e43e9f7d3709903650e40a850e10fcf5149ec8e67cb2914:headline:464d9378faabfa00",
      "before_evidence": "https://web.archive.org/web/20260908125936/https://www.boltbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Finding better ways to treat cancer” to “Bolt Biotherapeutics has acquired Prana Therapies in conjunction with a $120 million private placement.”.",
      "between": {
        "from": "2026-09-08T12:59:36.000Z",
        "to": "2026-10-24T05:41:13.000Z"
      },
      "evidence": "https://web.archive.org/web/20261024054113/https://www.boltbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Bolt Biotherapeutics” company record, https://startuphistory.org/c/boltbio.com"
}